8-Hydroxy-2-Deoxyguanosine ,Total Antioxidant Capacity in Oral Premalignant and Malignant Lesions
Detection of Salivary 8-Hydroxy-2-Deoxyguanosine and Total Antioxidant Capacity in Patients With Oral Premalignant and Malignant Lesions
1 other identifier
observational
120
1 country
1
Brief Summary
Objectives: Investigating the level of salivary 8-hydroxy-2-deoxyguanosine (8-OHdG) and total antioxidant capacity (TAC) in oral premalignant and malignant lesions in order to determine their diagnostic value for the malignant patients. Design: 120 subjects diagnosed with oral leukoplakia, oral lichen planus (OLP) and oral squamous cell carcinoma (OSCC) along with healthy control subjects were included. Salivary samples from all participants were collected. 8-OHdG was measured by ELISA technique and the TAC level was assessed by a photometric test system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedFirst Submitted
Initial submission to the registry
January 28, 2019
CompletedFirst Posted
Study publicly available on registry
February 5, 2019
CompletedFebruary 20, 2019
February 1, 2019
6 months
January 28, 2019
February 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Salivary 8-OHdG
8-OHdG have a critical role in the pathogenesis of malignant lesions
1 year
salivary TAC
OSCC might be used as a tool to help diagnosis of OSCC but not to differentiate between various malignant grades
1 year
Study Arms (4)
Group A
30 patients diagnosed with oral leukoplakia
Group B
30 patients diagnosed with oral lichen planus
Group C
30 patients having oral squamous cell carcinoma with the tongue being the most commonly affected site
Group D
30 age and gender matched individuals having no oral mucosal lesions acting as a control group
Eligibility Criteria
The included subjects were all assessed medically according to the modified Cornell Medical index (Kerr \& Millard, 1965).
You may qualify if:
- All included individuals were not under any current medication, suffering from any systemic condition or having any other oral mucosal disorder.
You may not qualify if:
- Pregnant or lactating females
- subjects having systemic disorder or taking medications;
- subjects who suffer from any other mucosal lesions.
- severe periodontal inflammation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sandy hassan shaaban
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer
Study Record Dates
First Submitted
January 28, 2019
First Posted
February 5, 2019
Study Start
April 1, 2018
Primary Completion
October 1, 2018
Study Completion
December 1, 2018
Last Updated
February 20, 2019
Record last verified: 2019-02